Phase II Iressa & Carbo/Gem in NSCLC

NCT00264498 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Gefitinib
DRUG: Gemcitabine
DRUG: Carboplatin

Sponsor

AstraZeneca